Renin and aldosterone are blood pressure hormones that help control sodium, potassium, fluid balance, anlly order them together when high blood pressure is hard to explain, blood pressure remains high despite several medications, potassium is low, or an adrenal hormone disorder is suspected. The result is rarely interpreted from one number alone. The pattern between aldosterone, renin, potassium, sodium intake, posture, and medications gives the useful information.
Aldosterone tells the kidneys to hold sodium and release potassium. Renin rises when the kidneys sense low blood flow, low sodium delivery, or reduced circulating volume. When aldosterone is high while renin is low, the pattern may point toward primary aldosteronism, a treatable cause of high blood pressure. When both are high, the body may be reacting to reduced kidney blood flow, diuretics, fluid loss, or heart or kidney disease. Careful preparation matters because common medicines and testing conditions can change the result.
- Renin and aldosterone are usually interpreted together, often as the aldosterone-renin ratio, rather than as separate “high” or “low” values.
- High aldosterone with low renin can suggest primary aldosteronism, especially when blood pressure is high or potassium is low.
- Low potassium does not have to be present; many people with primary aldosteronism have normal potassium.
- Medications can strongly affect results, especially diuretics, mineralocorticoid receptor blockers, ACE inhibitors, ARBs, beta blockers, and some calcium channel blockers.
- Typical ARR screening cutoffs vary by lab, but many use an aldosterone-renin ratio above about 20–30 when aldosterone is at least about 10–15 ng/dL.
- Urgent care is needed for severe symptoms, very high blood pressure, chest pain, weakness from abnormal potassium, fainting, confusion, or signs of stroke.
Table of Contents
- What Renin and Aldosterone Measure
- Why Doctors Order Renin and Aldosterone
- How the Aldosterone-Renin Ratio Is Used
- Common Result Patterns
- Preparation and Testing Conditions
- Follow-Up After Abnormal Results
- When to Seek Medical Care
What Renin and Aldosterone Measure
Renin and aldosterone are part of the renin-angiotensin-aldosterone system, often shortened to RAAS. This hormone system helps the body defend blood pressure and blood flow to vital organs. It is active every day, but it becomes especially important during dehydration, low salt intake, blood loss, kidney blood flow problems, and some forms of heart or kidney disease.
Renin is released by specialized cells in the kidneys. The kidneys release more renin when they sense lower blood pressure in the kidney arteries, reduced sodium delivery through the kidney tubules, or signals from the sympathetic nervous system. Renin starts a chain reaction that leads to angiotensin II, a hormone that tightens blood vessels and stimulates aldosterone release.
Aldosterone is made by the adrenal glands, which sit above the kidneys. Its main job is to help the kidneys retain sodium and water while excreting potassium and acid. This is why aldosterone problems often show up as blood pressure changes, potassium changes, or acid-base patterns on blood tests. When aldosterone is too high for the body’s needs, blood pressure may rise and potassium may fall. When aldosterone is too low, blood pressure may drop and potassium may rise.
Renin can be reported in two main ways. Plasma renin activity, or PRA, measures how much angiotensin I is generated over time and is often reported as ng/mL/hour. Direct renin concentration, or DRC, measures the amount of renin protein and may be reported as mU/L, ng/L, or another lab-specific unit. These two renin methods are not interchangeable.
Aldosterone is commonly reported as ng/dL in the United States or pmol/L in many other countries. Blood aldosterone changes with posture, time of day, sodium intake, menstrual cycle phase, kidney function, and medications. Urine aldosterone may also be measured during certain confirmatory tests.
Because lab methods differ, the reference range printed on the report matters more than a single universal range. A typical adult morning aldosterone range may be roughly 3–30 ng/dL depending on posture and sodium intake. A typical plasma renin activity range may be roughly 0.5–4.0 ng/mL/hour when upright, but this also varies widely by laboratory and clinical setting.
The hormone pattern is more useful than the isolated number. Aldosterone of 16 ng/dL may be appropriate if renin is high after dehydration, but concerning if renin is fully suppressed in a person with resistant hypertension. Likewise, low renin may be expected in someone taking a beta blocker, but more meaningful if medications and testing conditions have been adjusted.
Why Doctors Order Renin and Aldosterone
Doctors usually order renin and aldosterone when they suspect a hormone-driven blood pressure pattern. The most common reason is screening for primary aldosteronism, a condition in which one or both adrenal glands make too much aldosterone without the usual renin signal.
Primary aldosteronism is more common than once thought. It is especially worth considering when high blood pressure appears at a young age, requires several medications, comes with low potassium, or stays high despite treatment. It can also be considered when an adrenal nodule is found on imaging, when there is a family history of early stroke or early-onset hypertension, or when sleep apnea and resistant hypertension occur together.
Renin and aldosterone may also help evaluate secondary hyperaldosteronism. In this pattern, aldosterone is high because renin is high first. The adrenal glands are responding to a signal rather than acting independently. Causes can include diuretic use, dehydration, low effective circulating volume, heart failure, cirrhosis with fluid retention, kidney artery narrowing, and some kidney disorders.
These tests may be ordered when potassium is repeatedly abnormal. Low potassium can occur when aldosterone is too high, but it can also come from diuretics, vomiting, diarrhea, magnesium deficiency, certain kidney tubule disorders, or poor intake. A related article on low potassium blood test results can help place potassium into the wider electrolyte picture.
High potassium can point in the opposite direction, especially when aldosterone is low or the kidney cannot respond to aldosterone properly. This can happen with adrenal insufficiency, advanced kidney disease, certain blood pressure medicines, potassium-sparing diuretics, or severe illness. Kidney function and potassium should be reviewed together because reduced filtration can make potassium harder to excrete. The relationship between kidney markers and potassium is covered in more detail in potassium and creatinine interpretation.
Renin and aldosterone are not general wellness screening tests. They require context. Testing without a clear reason can create confusing results because mild highs and lows are common when sodium intake, posture, and medicines are not standardized. The test is most helpful when the clinician already has a specific question: Is aldosterone too high for the level of renin? Is renin driving aldosterone? Is a medication or kidney blood flow issue activating the RAAS?
How the Aldosterone-Renin Ratio Is Used
The aldosterone-renin ratio, or ARR, compares aldosterone with renin. It is most often used to screen for primary aldosteronism. The idea is simple: if aldosterone is inappropriately high and renin is suppressed, the ratio rises.
The ARR is a screening test, not a final diagnosis. A high ratio means the pattern deserves further evaluation. It does not prove that a person has an adrenal adenoma or needs surgery. A normal ratio also does not always rule out disease if preparation was poor, potassium was low, sodium intake was very low, or medications distorted the result.
With aldosterone reported in ng/dL and plasma renin activity reported in ng/mL/hour, many laboratories use a ratio above about 20–30 as a positive screen when aldosterone is at least about 10–15 ng/dL. Some centers use different cutoffs. Direct renin concentration uses a different denominator, so the cutoff is not the same. This is one reason the lab’s interpretation notes are important.
Aldosterone must be high enough to make the ratio meaningful. A very low renin value can mathematically inflate the ARR even when aldosterone is low or normal. For example, an aldosterone of 5 ng/dL with extremely low renin may produce a high-looking ratio, but that pattern is less convincing for primary aldosteronism than aldosterone of 18 ng/dL with suppressed renin.
ARR interpretation also depends on potassium. Low potassium can reduce aldosterone secretion and create a false-negative or less dramatic result. If potassium is low, clinicians often correct it before testing or before repeating the test. This is one reason aldosterone, renin, potassium, bicarbonate or carbon dioxide, creatinine, and medication history should be reviewed together. Related electrolyte testing is often part of an electrolyte panel or a metabolic panel.
The ratio is especially useful because primary aldosteronism can be clinically quiet. Many people do not have obvious symptoms. Some have normal potassium. Some have blood pressure that looks like ordinary essential hypertension. Without checking renin and aldosterone, the hormone pattern can be missed for years.
Why aldosterone alone is not enough
Aldosterone can rise normally when the body needs to hold salt and water. It may rise after dehydration, low sodium intake, standing upright, or diuretic use. In those cases, renin usually rises too. The body is asking for aldosterone.
In primary aldosteronism, renin is usually low because the body is already expanded with sodium and fluid. The kidneys sense that the RAAS signal should be turned down, but aldosterone remains too high. That mismatch is the signal.
Why renin alone is not enough
Low renin is common in older adults, in people with high salt intake, and in people taking beta blockers or certain other medicines. High renin is common with diuretics, ACE inhibitors, ARBs, sodium restriction, and dehydration. Renin becomes more informative when aldosterone and the clinical picture are considered at the same time.
Common Result Patterns
Renin and aldosterone results are best read as patterns. A single abnormal value may be a medication effect, posture effect, salt intake effect, or lab timing issue. The table below shows common patterns and the usual clinical interpretation.
| Pattern | Common meaning | Examples to consider |
|---|---|---|
| High aldosterone, low renin | Aldosterone is being produced without the usual renin signal | Primary aldosteronism, adrenal adenoma, bilateral adrenal hyperplasia, rare familial forms |
| High aldosterone, high renin | Aldosterone is responding to renin activation | Diuretics, dehydration, low sodium intake, kidney artery narrowing, heart failure, cirrhosis |
| Low aldosterone, high renin | The kidneys are asking for aldosterone, but the adrenal response is low | Adrenal insufficiency, hypoaldosteronism, medication effects, severe illness |
| Low aldosterone, low renin | The RAAS signal is suppressed overall | High sodium intake, beta blockers, low-renin hypertension, licorice effect, Liddle-like patterns |
| Normal aldosterone, very low renin | May still be suspicious if blood pressure is high and aldosterone is not appropriately suppressed | Early or milder primary aldosteronism, medication effect, high sodium intake |
The classic primary aldosteronism pattern is high aldosterone with suppressed renin. Potassium may be low, but normal potassium does not exclude it. When potassium is low, symptoms can include muscle weakness, cramps, constipation, palpitations, frequent urination, or unusual fatigue. Some people have no symptoms and discover the pattern only because blood pressure is difficult to control.
High aldosterone with high renin is different. In that situation, the adrenal gland may be doing what it was asked to do. The question becomes why renin is high. Diuretic use is a common explanation. Dehydration, vomiting, diarrhea, very low sodium intake, reduced kidney blood flow, and certain heart or liver conditions can also raise renin. Kidney artery narrowing is one important cause because the affected kidney may behave as if the body’s blood pressure is too low, even when arm blood pressure is high.
Low aldosterone with high renin can suggest that the adrenal glands are not producing enough aldosterone for the body’s needs. This may happen in adrenal insufficiency, certain inherited enzyme disorders, severe illness, or medication-related hypoaldosteronism. It may come with low blood pressure, salt craving, dizziness, dehydration, or high potassium. If cortisol is also low, adrenal insufficiency becomes more urgent.
Low renin and low aldosterone can occur when the body’s RAAS is shut down. High sodium intake can suppress both. Beta blockers can suppress renin. Licorice or glycyrrhizin can mimic aldosterone effects by allowing cortisol to activate mineralocorticoid receptors, often causing high blood pressure and low potassium with low renin and low aldosterone. Some rare genetic kidney channel disorders can create a similar pattern.
The pattern should also be compared with kidney function. Creatinine and estimated glomerular filtration rate show how well the kidneys filter blood, while renin and aldosterone show hormonal regulation of pressure and electrolytes. If filtration markers are abnormal, interpretation becomes more complex. A broader look at creatinine and eGFR can help separate kidney filtration concerns from hormone signaling concerns.
Preparation and Testing Conditions
Renin and aldosterone are sensitive tests. Preparation does not need to be perfect in every situation, but the clinician must know the testing conditions. A result drawn at the wrong time, during a medication change, after dehydration, or during very low sodium intake may be misleading.
Many clinicians prefer morning testing after the person has been awake for at least two hours and seated for 5–15 minutes before the draw, though protocols vary. Some labs specify upright, seated, or supine collection. The posture must match the lab’s reference range because standing raises renin and aldosterone compared with lying down.
Sodium intake matters. Very low sodium intake can raise renin and aldosterone, potentially masking a high-ratio pattern. Very high sodium intake can suppress renin and sometimes aldosterone. For primary aldosteronism screening, clinicians often prefer that the person not intentionally restrict sodium before testing unless there is a medical reason to do so.
Potassium should be checked and corrected when low. Low potassium can blunt aldosterone release. If the goal is to screen for primary aldosteronism, an uncorrected low potassium level may make aldosterone look less elevated than it truly is.
Medication effects are often the hardest part. Some medicines can be safely paused or changed before testing, but this must be done by the prescribing clinician. People should not stop blood pressure medication on their own, especially if blood pressure is high or there is a history of stroke, heart disease, kidney disease, or severe hypertension.
| Medication group | Typical effect | Possible testing issue |
|---|---|---|
| Mineralocorticoid receptor blockers such as spironolactone and eplerenone | Raise renin and can raise aldosterone | May lower the ARR and hide primary aldosteronism |
| Amiloride and triamterene | Raise renin by blocking sodium reabsorption effects | May interfere with screening |
| Loop and thiazide diuretics | Raise renin and aldosterone through volume and sodium effects | May lower or distort the ARR |
| ACE inhibitors and ARBs | Raise renin and may lower aldosterone | May lower the ARR |
| Beta blockers | Suppress renin | May raise the ARR falsely |
| Central alpha-2 agonists such as clonidine | Suppress sympathetic renin release | May raise the ARR falsely |
| Dihydropyridine calcium channel blockers | May raise renin | Can reduce the ARR in some people |
When medication changes are needed, clinicians sometimes use alternatives that interfere less with ARR interpretation, such as verapamil sustained release, hydralazine, or certain alpha blockers. The choice depends on blood pressure, heart rate, kidney function, and other conditions.
Testing during acute illness can also mislead. Vomiting, diarrhea, dehydration, hospitalization, severe pain, and rapid changes in kidney function can all activate RAAS. In many nonurgent cases, repeat testing under more stable conditions gives a clearer answer.
Salt supplements, potassium supplements, nonsteroidal anti-inflammatory drugs, oral contraceptives, hormone therapy, licorice products, and herbal products may also matter. The lab requisition rarely captures all of these details, so the medication and supplement list should be reviewed with the clinician.
Follow-Up After Abnormal Results
An abnormal renin and aldosterone pattern usually leads to a repeat test, a confirmatory test, or additional blood and urine studies. The next step depends on how strong the pattern is and how much risk the person has.
When primary aldosteronism is suspected, clinicians often repeat the ARR under better conditions if the first test was borderline or affected by medications. If the pattern is strongly positive, confirmatory testing may follow. Common confirmatory tests include saline infusion, oral sodium loading with urine aldosterone, fludrocortisone suppression, or captopril challenge. Each test asks whether aldosterone suppresses normally when the body should turn it down.
Some people with very clear findings may not need every confirmatory step. For example, a person with high blood pressure, spontaneous low potassium, suppressed renin, and clearly high aldosterone may move more quickly to subtype evaluation. This decision depends on specialist judgment and local protocols.
After biochemical confirmation, the next question is whether aldosterone excess is coming from one adrenal gland or both. A CT scan can look for adrenal nodules, but imaging alone can mislead because nonfunctioning adrenal nodules become more common with age. A small aldosterone-producing area may not be visible, while a visible nodule may not be the source of aldosterone. When surgery is being considered, adrenal venous sampling is often used to compare hormone production from the right and left adrenal veins.
Treatment depends on the source. If one adrenal gland is clearly overproducing aldosterone and the person is a surgical candidate, adrenalectomy may improve or cure the hormone problem. Blood pressure may improve quickly, but some people still need medication afterward, especially if hypertension has been present for many years or if blood vessels and kidneys have already adapted.
If both adrenal glands are overproducing aldosterone, or if surgery is not preferred, treatment usually involves mineralocorticoid receptor blockers such as spironolactone or eplerenone. These medicines block aldosterone’s effect. They can lower blood pressure, raise potassium toward normal, and reduce excess aldosterone signaling. Monitoring is important because potassium and kidney function can change after treatment begins.
Some people need a broader kidney and electrolyte evaluation. A renal function panel may include creatinine, BUN, electrolytes, albumin, calcium, and phosphorus. The difference between general metabolic testing and kidney-focused testing is discussed in kidney function panel vs CMP. When aldosterone excess is suspected, potassium, bicarbonate or carbon dioxide, creatinine, and urine electrolytes may all add useful context.
If renin and aldosterone are both high, the follow-up often focuses on causes of RAAS activation. The clinician may review diuretic dose, sodium intake, dehydration, kidney function, urine protein, heart function, liver disease, and possible kidney artery narrowing. Imaging of kidney blood flow may be considered when blood pressure is resistant, kidney function worsens after ACE inhibitor or ARB treatment, an abdominal bruit is heard, or one kidney is smaller than the other.
If aldosterone is low and potassium is high, follow-up may include cortisol testing, ACTH, adrenal antibodies, medication review, kidney function assessment, and sometimes evaluation for hyporeninemic hypoaldosteronism. This pattern is seen more often in people with diabetes, chronic kidney disease, or medications that reduce aldosterone production or action.
When to Seek Medical Care
Renin and aldosterone results usually do not create an emergency by themselves. The urgency comes from blood pressure level, potassium level, symptoms, and kidney function.
Seek urgent medical care for chest pain, shortness of breath, one-sided weakness, trouble speaking, fainting, confusion, severe headache with very high blood pressure, or new vision changes. These symptoms can reflect dangerous complications of severe hypertension or a vascular event.
Very high or very low potassium can affect heart rhythm and muscle function. Urgent evaluation is important for severe weakness, paralysis, palpitations, fainting, or abnormal heart rhythm symptoms, especially when a potassium result is clearly outside the lab’s safe range. Potassium problems are more concerning when kidney function is reduced or when a person is taking ACE inhibitors, ARBs, spironolactone, eplerenone, amiloride, trimethoprim, or potassium supplements.
Blood pressure also changes the level of concern. A single high reading after stress or caffeine is different from repeated readings above 180/120 mmHg. Severe readings with symptoms need urgent care. Severe readings without symptoms still need prompt medical advice because medication adjustment may be needed.
People with persistent hypertension should not wait for low potassium before asking about aldosterone. Primary aldosteronism can exist with normal potassium. It is especially reasonable to discuss screening when blood pressure needs three or more medicines, when hypertension starts young, when there is an adrenal incidentaloma, or when there is a family history of early stroke or early severe hypertension.
The results should be interpreted with the clinician who ordered the test. The report may label a result “normal” or “abnormal,” but the clinical meaning depends on posture, collection time, sodium intake, potassium level, kidney function, and medications. A carefully repeated test is often more useful than acting on one imperfect sample.
References
- The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline 2016 (Guideline)
- The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study 2020 (Cross-sectional Study)
- Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study 2022 (Cohort Study)
- Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis 2020 (Systematic Review)
- Primary Aldosteronism 2025 (Laboratory Guidance)
- Aldosterone-Renin Ratio 2025 (Laboratory Guidance)
Disclaimer
Renin and aldosterone results should be interpreted by a qualified clinician because posture, sodium intake, potassium level, kidney function, and medications can all change the pattern. Do not stop blood pressure medicine, diuretics, potassium supplements, or hormone-related medications to prepare for testing unless the prescribing clinician tells you to do so. Seek urgent medical care for severe blood pressure symptoms, chest pain, stroke-like symptoms, fainting, severe weakness, or symptoms of a dangerous potassium abnormality.
